Reprogramming CAR T Cells for Tumor-Targeted Therapy
Recent advances in cancer immunotherapy have been revolutionized by the precise engineering of chimeric antigen receptor (CAR) T cells to deliver therapeutic payloads selectively within tumors. A groundbreaking study led by Chen et al. has demonstrated a novel approach that harnesses endogenous gene promoters to tightly control the expression of immunomodulatory cytokines, thus enhancing antitumor […]
Recent advances in cancer immunotherapy have been revolutionized by the precise engineering of chimeric antigen receptor (CAR) T cells to deliver therapeutic payloads selectively within tumors. A groundbreaking study led by Chen et al. has demonstrated a novel approach that harnesses endogenous gene promoters to tightly control the expression of immunomodulatory cytokines, thus enhancing antitumor […]
What's Your Reaction?
